Why doctor-led aesthetics matters: what to look for before booking.

Who can perform aesthetic treatments in the UK?

The short answer is: more people than you might expect. For most of the past decade, aesthetic injections in the UK existed in a largely unregulated space. Someone with a one-day training course and a product supplier could legally offer botulinum toxin and dermal filler treatments to the public.

That has begun to change. Since 2024, regulations in England require that prescription-only aesthetic treatments be performed by or under the supervision of a registered healthcare professional. But the shift is gradual, the landscape is still inconsistent, and the responsibility for checking credentials largely falls on the patient.

Practitioners currently offering aesthetic treatments include GMC-registered doctors, NMC-registered nurses with prescribing qualifications, GDC-registered dentists, and at the unqualified end of the market, aestheticians and beauty therapists with cosmetic certification. The training behind these categories varies enormously.

The 2024 regulatory changes: what actually changed

From 1 September 2024, Schedule 7 of the Health and Care Act 2022 came into force in England, introducing a formal legal requirement that certain aesthetic injectable procedures be performed by or under the direct oversight of a registered healthcare professional with prescribing authority. The procedures covered include the administration of botulinum toxin and hyaluronic acid fillers, the two treatments most commonly offered in the aesthetic market.

Under this framework, the qualifying practitioners are GMC-registered medical doctors, NMC-registered nurses who hold an independent prescribing qualification, and GDC-registered dentists. The legislation explicitly excludes aestheticians, beauty therapists, and lay practitioners from performing these procedures independently, regardless of the level of cosmetic training they may hold or the number of treatments they have administered.

The change came after years of sustained pressure from medical bodies, patient advocacy groups, and regulatory authorities, following a documented accumulation of cases in which serious harm, vascular occlusion, tissue necrosis, disfigurement, resulted from treatment by practitioners without the clinical training to prevent or manage complications. The principle behind the change is that treatments carrying genuine medical risk should require genuine medical oversight.

Enforcement remains imperfect. The market in 2026 still contains practitioners operating outside this framework, and a patient booking an appointment through social media cannot always know whether the clinic they are contacting is operating within the new regulations. This is why verifying credentials independently, rather than relying on the practitioner’s own claims about their qualifications, remains the most reliable protection available to patients.

What ‘under the supervision of’ means in practice

The phrase “under the supervision of a registered healthcare professional” in the 2024 regulations contains a degree of ambiguity that some clinics have exploited. In the most minimal interpretation, a clinic could appoint a GMC-registered doctor as a nominal clinical lead, place their name on the clinic’s regulatory paperwork, and continue operating largely as before, with the prescribing doctor rarely or never present during actual treatment sessions.

This arrangement is not what the regulations intend, and it is not what meaningful clinical supervision looks like. Proper supervision means the qualified practitioner is directly responsible for each individual patient: taking the medical history, assessing suitability, forming the treatment recommendation, and either administering the treatment personally or being present and directly overseeing it. Being theoretically contactable in an emergency is not supervision. It is a liability arrangement designed to satisfy paperwork rather than to protect patients.

Patients should ask directly: who will be assessing me, and who will be treating me? Are they the same person? Are they GMC registered, and can I check their registration number? If the answers are vague, or if the practitioner assessing you and the one prescribing for you are different people operating at arm’s length, the standard of clinical oversight is lower than it should be.

Remote prescribing: what it is and why it matters

Before the 2024 regulations, one of the most common routes by which non-prescribing practitioners obtained botulinum toxin for aesthetic use was through a remote prescribing arrangement. Under this model, a prescribing doctor, often connected to the practitioner through a third-party prescribing service, would issue a prescription for a patient they had never met, on the basis of information provided by the treating practitioner or by a brief online form completed by the patient.

This practice has been consistently and explicitly criticised by the GMC and by other regulatory bodies as inappropriate. The core problem is that a prescription for a prescription-only medicine is a clinical decision. It should be based on direct assessment of the individual patient, their medical history, their anatomy, their suitability for the proposed treatment. A prescription issued by a doctor who has never met the patient, based on a form or a third-party account, is not a clinical decision. It is an administrative workaround designed to make an otherwise non-compliant arrangement appear legitimate.

Under the 2024 regulations, the expectation is that the prescribing professional has directly assessed the patient. Remote prescribing arrangements of the kind described above are inconsistent with this standard. Patients should know that if a clinic uses a remote prescriber, a prescribing doctor who does not form part of the clinical team and does not see patients in person, the standard of prescribing oversight is substantively lower than what the regulations intended to require.

What medical training actually gives a doctor in aesthetic practice

A doctor’s qualification requires a minimum of five years of full-time undergraduate medical education, followed by a foundation programme of clinical practice and typically further specialty training. Over that period, the training covers anatomy at a clinical level of detail, pharmacology relevant to injection and anaesthetic treatments, the recognition and management of adverse events and medical emergencies, dermatology and the structure and function of skin, and the complex interaction of systemic health conditions with procedural interventions.

The anatomical knowledge a doctor brings to aesthetic practice is qualitatively different from the anatomy component of an aesthetics training course. Understanding where the facial artery branches, where the supratrochlear and supraorbital vessels run, how the layers of the face differ in structure across different patients and different areas, and where the danger zones for vascular occlusion are located, this knowledge is a product of years of clinical training and cadaveric anatomy, not an afternoon module.

For a dermatologist specifically, there is additional training in skin conditions, skin histology, the photoageing process, and the relationship between skin health and the ageing changes that aesthetic treatments are designed to address. This background shapes how a dermatologist approaches the face in an aesthetic context. The question is not only “what treatment would address this concern?” but also “what is the underlying skin health picture, and how does that context affect what is appropriate?”

This level of background is not available from an aesthetics course of any length. Short courses can teach injection technique. They cannot compress the clinical reasoning that takes years of medical practice to develop. The gap between a doctor and a non-medical practitioner is not primarily a gap in technical execution. It is a gap in the clinical framework within which that technique is applied.

What doctor-led actually means in practice

A doctor-led aesthetic clinic is one where a GMC-registered medical doctor is responsible for your assessment, your prescription, and your treatment plan. That matters for several reasons:

• Prescribing authority. Botulinum toxin is a prescription-only medicine. A doctor can legally prescribe it for you following assessment. Non-prescribing practitioners must obtain a prescription from a remote prescriber who has never met you, a practice that regulators have consistently flagged as inappropriate.
• Medical training. A doctor’s training includes anatomy, pharmacology, dermatology, and the recognition of adverse events. When something goes wrong with an aesthetic procedure, a trained doctor can identify and manage the complication in a way that many non-medical practitioners cannot.
• Regulatory accountability. GMC registration means a doctor is accountable to a formal regulatory body with the power to suspend or remove their licence to practise. That accountability changes how treatment decisions are made.
• Context for your health. A doctor considers your overall medical history, not just your aesthetic concern. Certain medications, conditions, and previous procedures are directly relevant to treatment safety. A doctor is better placed to identify those interactions.

BCAM in more detail: what the membership actually requires

The British College of Aesthetic Medicine is a professional body for medical doctors practising aesthetic medicine in the UK. BCAM Full Membership is not an entry-level credential that any doctor can acquire by attending a short course. It requires the applicant to be a fully registered medical doctor, to have undertaken relevant aesthetic training at a clinical level, to carry appropriate medical indemnity insurance, and to comply with BCAM standards of practice including ongoing continuing professional development requirements.

BCAM membership creates an accountability layer beyond the GMC. A BCAM full member who fails to meet the organisation’s standards of practice faces professional consequences within that framework as well as the GMC’s regulatory framework. The combination of GMC registration and BCAM full membership places a practitioner within two overlapping accountability structures, both of which have real consequences for professional conduct.

Other meaningful markers of professional accountability in the aesthetics sector include CPSA (Cosmetic Practice Standards Authority) accreditation, which sets clinic-level standards, and voluntary registration with organisations such as the JCCP (Joint Council for Cosmetic Practitioners). These organisations exist because the aesthetics sector recognised that the market needed accountability structures beyond what general medical regulation provides. Their presence in a practitioner’s credentials is a positive signal. Their absence is neutral, but the combination of GMC registration and BCAM full membership provides a solid foundation of verifiable accountability.

Dr Andrew Winter is a BCAM full member, a retired NHS consultant dermatologist with more than 30 years of clinical experience, and is GMC-registered (GMC 2584423). His background is in skin, not beauty, which shapes how treatment is approached and what he considers relevant to discuss before any recommendation is made.

What BCAM membership indicates

The British College of Aesthetic Medicine (BCAM) is a professional body for medical doctors practising aesthetic medicine. Full membership requires medical qualification, adherence to BCAM standards of practice, and ongoing professional development. It is not a guarantee of any particular outcome, but it is a meaningful credential that places a practitioner within a medically governed framework.

Questions worth asking, and what the answers should look like

Before committing to any aesthetic treatment, these are the questions worth raising with a prospective practitioner, along with an honest account of what reassuring and concerning answers look like:

Are you GMC, NMC, or GDC registered? A reassuring answer is immediate and specific: yes, GMC registered, registration number [number], which you can verify at the GMC website. A concerning answer involves vagueness, a mention of a different regulatory body (“I’m regulated by…” followed by an aesthetic trade body rather than a statutory regulator), or any degree of reluctance to provide a verifiable registration number.

Do you prescribe for me yourself, or is a remote prescriber involved? A reassuring answer: “I prescribe for you directly, following our consultation, based on my assessment of your suitability.” A concerning answer: “We work with a prescribing doctor who reviews the notes,” or “I use a prescribing service.” These answers describe arrangements in which the prescribing decision is separated from the clinical assessment, which is not what a direct prescriber relationship looks like.

Is the consultation separate from treatment? A reassuring answer: “Your first appointment is a consultation only, we discuss findings and options, and if you decide to proceed, we arrange a treatment appointment separately.” A concerning answer: “We offer a consultation and treatment on the same day, many patients prefer to get it done in one visit.” Same-day treatment is not inherently wrong in every context, but when combined with other signals, it often indicates that the consultation is nominal rather than clinical.

What happens if I have a complication? A reassuring answer is specific: it describes what the practitioner would assess, what treatment they can administer (for example, hyaluronidase for filler complications, or the ability to recognise and refer vascular occlusion immediately), and how to contact them outside normal hours if a problem develops after the appointment. A concerning answer is dismissive: “Complications are extremely rare with us,” or “I’ve never had that happen.” These answers avoid the question rather than addressing it.

Why Dr Winter approaches practice this way

Dr Andrew Winter spent more than 30 years as an NHS consultant dermatologist before moving to aesthetic practice. That clinical background is not incidental to how he runs his clinic, it is the foundation of it.

In NHS dermatology, the decision not to treat is as important, and as clinically demanding, as the decision to treat. A consultant dermatologist spends a considerable proportion of their working life explaining to patients why the intervention they came hoping for is not the right answer for them, and why the alternative being recommended, while perhaps less satisfying in the short term, is more appropriate. This capacity for the clinical no is not something that aesthetic training teaches. It is something that medical practice, particularly at a senior level, develops over years.

Dr Winter brings that same thinking to aesthetic medicine. A consultation that concludes no treatment is appropriate is not a failed appointment. It is the assessment process working correctly. He applies the same clinical standards to the aesthetic context that he applied to the dermatological one, which means that the primary question is always whether treatment is appropriate for this patient, not whether it is commercially desirable for the clinic.

This is what doctor-led aesthetics looks like when it is applied consistently. Not as a marketing phrase, but as a clinical standard that determines how every consultation is structured and every recommendation is made.

A quieter route into cosmetic dermatology

Dr Andrew Winter sees patients at two locations: Room 1, 20 Sandy Lane, Prestwich, and 1 The Shires, Moss Lane, Moore, Warrington. Appointments begin with a consultation. There is no upselling, no pre-set treatment packages, and no same-day injection without assessment.

If you are considering any aesthetic treatment and want a medical opinion before committing, a consultation is the right first step.

Frequently asked questions

Related reading

• How much does anti-wrinkle treatment cost near Manchester?: how practitioner qualification affects pricing and what the market looks like in 2026.
• What to expect at your first aesthetic consultation: a walkthrough of what a proper medical consultation involves.
• Dr Andrew Winter, background and credentials: Dr Winter’s qualifications, training, and approach to practice.